Back
G1 Therapeutics 10K Form
Sell
41
GTHX
G1 Therapeutics
Last Price:
4.48
Seasonality Move:
16.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GTHX News And Ratings
See the #1 stock for the next 7 days that we like better than GTHX
GTHX Financial Statistics
Sales & Book Value
| Annual Sales: | $82.51M |
|---|---|
| Cash Flow: | $-12.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.68 |
| Price / Book: | 6.09 |
Profitability
| EPS (TTM): | -0.95000 |
|---|---|
| Net Income (TTM): | $-47.97M |
| Gross Margin: | $75.32M |
| Return on Equity: | -96.05% |
| Return on Assets: | -31.87% |
G1 Therapeutics Earnings Forecast
Key G1 Therapeutics Financial Ratios
- The Gross Profit Margin over the past 5 years for GTHX is 91.28%.
- The Selling, General & Administrative Expenses for GTHX have been equal to 86.21% of Gross Profit Margin.
- The Research & Development expenses have been 52.98% of Revenue.
- The Interest Expense is -20.93% of Operating Income.
- The Net Earning history of GTHX is -58.13% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
G1 Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GTHX |
| CUSIP: | 3621LQ |
| Website: | g1therapeutics.com |
Debt
| Debt-to-Equity Ratio: | 1.46 |
|---|---|
| Current Ratio: | 3.87 |
| Quick Ratio: | 3.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GTHX Technical Analysis vs Fundamental Analysis
Sell
41
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy or a Sell?
-
G1 Therapeutics stock is rated a Sell
The current G1 Therapeutics [GTHX] share price is $4.13. The Score for GTHX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.